EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
09.03.26
/
50%
€13.50
Target price
09.03.27
€30.36
Performance (%)
-19.97%
Price
24.07.26
€10.70
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.97%. This prediction currently runs until 09.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.727% | -2.727% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its price target raised by Citigroup Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.89
07.01.25
07.01.25
€31.74
07.01.26
07.01.26
63.26%
08.01.26
08.01.26
